140 related articles for article (PubMed ID: 37616523)
1. Glycosylated fibronectin improves first-trimester prediction of pre-eclampsia.
Moungmaithong S; Wang X; Lau CSL; Tse AWT; Lee NMW; Leung HHY; Poon LC; Sahota DS
Ultrasound Obstet Gynecol; 2023 Oct; 62(4):512-521. PubMed ID: 37616523
[TBL] [Abstract][Full Text] [Related]
2. Screening for pre-eclampsia by maternal serum glycosylated fibronectin at 11-13 weeks' gestation.
Sokratous N; Bednorz M; Sarli P; Morillo Montes OE; Syngelaki A; Wright A; Nicolaides KH
Ultrasound Obstet Gynecol; 2023 Oct; 62(4):504-511. PubMed ID: 37401855
[TBL] [Abstract][Full Text] [Related]
3. Screening for pre-eclampsia by maternal serum glycosylated fibronectin and angiogenic markers at 36 weeks' gestation.
Sokratous N; Wright A; Syngelaki A; Kakouri E; Laich A; Nicolaides KH
Ultrasound Obstet Gynecol; 2024 Jan; 63(1):88-97. PubMed ID: 37724582
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of first trimester maternal serum inhibin-A for preeclampsia screening.
Moungmaithong S; Kwan AH; Tse AW; Wong NK; Lam MS; Wang J; Poon LC; Sahota DS
PLoS One; 2023; 18(7):e0288289. PubMed ID: 37428792
[TBL] [Abstract][Full Text] [Related]
5. Screening for pre-eclampsia at 11-13 weeks' gestation: use of pregnancy-associated plasma protein-A, placental growth factor or both.
Mazer Zumaeta A; Wright A; Syngelaki A; Maritsa VA; Da Silva AB; Nicolaides KH
Ultrasound Obstet Gynecol; 2020 Sep; 56(3):400-407. PubMed ID: 32441401
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic accuracy of first-trimester combined screening for early-onset and preterm pre-eclampsia at 8-10 compared with 11-13 weeks' gestation.
Mendoza M; Garcia-Manau P; Arévalo S; Avilés M; Serrano B; Sánchez-Durán MÁ; Garcia-Ruiz I; Bonacina E; Carreras E
Ultrasound Obstet Gynecol; 2021 Jan; 57(1):84-90. PubMed ID: 32388877
[TBL] [Abstract][Full Text] [Related]
7. Routine first-trimester combined screening for pre-eclampsia: pregnancy-associated plasma protein-A or placental growth factor?
Noël L; Guy GP; Jones S; Forenc K; Buck E; Papageorghiou AT; Thilaganathan B
Ultrasound Obstet Gynecol; 2021 Oct; 58(4):540-545. PubMed ID: 33998078
[TBL] [Abstract][Full Text] [Related]
8. Performance of first-trimester combined screening for preterm pre-eclampsia: findings from cohort of 10 110 pregnancies in Spain.
Cuenca-Gómez D; de Paco Matallana C; Rolle V; Valiño N; Revello R; Adiego B; Mendoza M; Molina FS; Carrillo MP; Delgado JL; Wright A; Santacruz B; Gil MM
Ultrasound Obstet Gynecol; 2023 Oct; 62(4):522-530. PubMed ID: 37099759
[TBL] [Abstract][Full Text] [Related]
9. Prospective evaluation of screening performance of first-trimester prediction models for preterm preeclampsia in an Asian population.
Chaemsaithong P; Pooh RK; Zheng M; Ma R; Chaiyasit N; Tokunaka M; Shaw SW; Seshadri S; Choolani M; Wataganara T; Yeo GSH; Wright A; Leung WC; Sekizawa A; Hu Y; Naruse K; Saito S; Sahota D; Leung TY; Poon LC
Am J Obstet Gynecol; 2019 Dec; 221(6):650.e1-650.e16. PubMed ID: 31589866
[TBL] [Abstract][Full Text] [Related]
10. Prediction of pre-eclampsia in twin pregnancy by maternal factors and biomarkers at 11-13 weeks' gestation: data from EVENTS trial.
Benkő Z; Wright A; Rehal A; Cimpoca B; Syngelaki A; Delgado JL; Tsokaki T; De Alvarado M; Vojtassakova D; Malligiannis Ntalianis K; Chaveeva P; Del Campo A; De Ganzo T; Resta C; Atanasova V; Accurti V; Villalain C; Aguilera J; Dojcinovska D; O'Gorman N; Plasencia W; Zingler E; Dutemeyer V; Alvar B; Casanova MC; Nicolaides KH
Ultrasound Obstet Gynecol; 2021 Feb; 57(2):257-265. PubMed ID: 33142361
[TBL] [Abstract][Full Text] [Related]
11. Prospective evaluation of first-trimester screening strategy for preterm pre-eclampsia and its clinical applicability in China.
Hu J; Gao J; Liu J; Meng H; Hao N; Song Y; Ma L; Luo W; Sun J; Gao W; Meng W; Sun Y
Ultrasound Obstet Gynecol; 2021 Oct; 58(4):529-539. PubMed ID: 33817865
[TBL] [Abstract][Full Text] [Related]
12. First-trimester pre-eclampsia biomarker profiles in Asian population: multicenter cohort study.
Chaemsaithong P; Sahota D; Pooh RK; Zheng M; Ma R; Chaiyasit N; Koide K; Shaw SW; Seshadri S; Choolani M; Panchalee T; Yapan P; Sim WS; Sekizawa A; Hu Y; Shiozaki A; Saito S; Leung TY; Poon LC
Ultrasound Obstet Gynecol; 2020 Aug; 56(2):206-214. PubMed ID: 31671479
[TBL] [Abstract][Full Text] [Related]
13. ASPRE trial: risk factors for development of preterm pre-eclampsia despite aspirin prophylaxis.
Shen L; Martinez-Portilla RJ; Rolnik DL; Poon LC
Ultrasound Obstet Gynecol; 2021 Oct; 58(4):546-552. PubMed ID: 33998099
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of screening performance of first-trimester competing-risks prediction model for small-for-gestational age in Asian population.
Nguyen-Hoang L; Papastefanou I; Sahota DS; Pooh RK; Zheng M; Chaiyasit N; Tokunaka M; Shaw SW; Seshadri S; Choolani M; Yapan P; Sim WS; Poon LC;
Ultrasound Obstet Gynecol; 2024 Mar; 63(3):331-341. PubMed ID: 37552550
[TBL] [Abstract][Full Text] [Related]
15. Ophthalmic artery Doppler in combination with other biomarkers in prediction of pre-eclampsia at 19-23 weeks' gestation.
Sapantzoglou I; Wright A; Arozena MG; Campos RV; Charakida M; Nicolaides KH
Ultrasound Obstet Gynecol; 2021 Jan; 57(1):75-83. PubMed ID: 33142353
[TBL] [Abstract][Full Text] [Related]
16. The International Federation of Gynecology and Obstetrics (FIGO) initiative on pre-eclampsia: A pragmatic guide for first-trimester screening and prevention.
Poon LC; Shennan A; Hyett JA; Kapur A; Hadar E; Divakar H; McAuliffe F; da Silva Costa F; von Dadelszen P; McIntyre HD; Kihara AB; Di Renzo GC; Romero R; D'Alton M; Berghella V; Nicolaides KH; Hod M
Int J Gynaecol Obstet; 2019 May; 145 Suppl 1(Suppl 1):1-33. PubMed ID: 31111484
[TBL] [Abstract][Full Text] [Related]
17. STATIN trial: predictive performance of competing-risks model in screening for pre-eclampsia at 35-37 weeks' gestation.
Döbert M; Wright A; Varouxaki AN; Mu AC; Syngelaki A; Rehal A; Delgado JL; Akolekar R; Muscettola G; Janga D; Singh M; Martin-Alonso R; Dütemeyer V; De Alvarado M; Atanasova V; Wright D; Nicolaides KH
Ultrasound Obstet Gynecol; 2022 Jan; 59(1):69-75. PubMed ID: 34580947
[TBL] [Abstract][Full Text] [Related]
18. Validation of machine-learning model for first-trimester prediction of pre-eclampsia using cohort from PREVAL study.
Gil MM; Cuenca-Gómez D; Rolle V; Pertegal M; Díaz C; Revello R; Adiego B; Mendoza M; Molina FS; Santacruz B; Ansbacher-Feldman Z; Meiri H; Martin-Alonso R; Louzoun Y; De Paco Matallana C
Ultrasound Obstet Gynecol; 2024 Jan; 63(1):68-74. PubMed ID: 37698356
[TBL] [Abstract][Full Text] [Related]
19. Screening for pre-eclampsia by maternal factors and biomarkers at 11-13 weeks' gestation.
Tan MY; Syngelaki A; Poon LC; Rolnik DL; O'Gorman N; Delgado JL; Akolekar R; Konstantinidou L; Tsavdaridou M; Galeva S; Ajdacka U; Molina FS; Persico N; Jani JC; Plasencia W; Greco E; Papaioannou G; Wright A; Wright D; Nicolaides KH
Ultrasound Obstet Gynecol; 2018 Aug; 52(2):186-195. PubMed ID: 29896812
[TBL] [Abstract][Full Text] [Related]
20. Ophthalmic artery Doppler in combination with other biomarkers in prediction of pre-eclampsia at 35-37 weeks' gestation.
Sarno M; Wright A; Vieira N; Sapantzoglou I; Charakida M; Nicolaides KH
Ultrasound Obstet Gynecol; 2021 Apr; 57(4):600-606. PubMed ID: 33073902
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
